Free Trial

Collegium Pharmaceutical (COLL) SEC Filings & 10K Form

Collegium Pharmaceutical logo
$28.82 -0.65 (-2.21%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$28.83 +0.01 (+0.03%)
As of 05/22/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Collegium Pharmaceutical SEC Filings

DateFilerForm TypeView
05/19/2025
4:35 PM
Collegium Pharmaceutical (Issuer)
Paya Carlos V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/19/2025
4:37 PM
Collegium Pharmaceutical (Issuer)
Paya Carlos V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:39 PM
Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:42 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:42 PM
Balice-Gordon Rita J. (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:42 PM
BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:43 PM
Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:43 PM
Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
7:10 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2025
10:04 AM
Collegium Pharmaceutical (Subject)
Pacer Advisors, Inc. (Filed by)
Form SCHEDULE 13G/A
05/02/2025
9:33 AM
Collegium Pharmaceutical (Subject)
Pacer Advisors, Inc. (Filed by)
Form SCHEDULE 13G
04/28/2025
6:56 AM
BlackRock, Inc. (Filed by)
Collegium Pharmaceutical (Subject)
Form SCHEDULE 13G/A
03/24/2025
4:05 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:06 PM
Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
3:35 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/21/2025
3:21 PM
Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:32 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:17 PM
Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:19 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
3:34 PM
Collegium Pharmaceutical (Issuer)
Dieter David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:36 PM
Collegium Pharmaceutical (Issuer)
Dieter David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:18 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4/A
03/18/2025
4:34 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
6:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
3:49 PM
Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
3:50 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:13 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
5:48 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:43 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
3:05 PM
Collegium Pharmaceutical (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2025
9:42 AM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
2:03 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:03 PM
Collegium Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/07/2025
12:21 PM
Collegium Pharmaceutical (Subject)
Invesco Ltd. (Filed by)
Form SCHEDULE 13G
02/05/2025
4:30 PM
Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/05/2025
4:30 PM
Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
3:12 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump wipes out trillions overnight… (Ad)

Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.

Whether you take some of that wealth for yourself depends on if you watch this controversial exposé
11/14/2024
3:50 PM
Collegium Pharmaceutical (Issuer)
Karnani Vikram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:13 PM
Collegium Pharmaceutical (Subject)
PRINCIPAL GLOBAL INVESTORS (Filed by)
Form SC 13G
11/13/2024
3:30 PM
Collegium Pharmaceutical (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
11/13/2024
1:39 PM
Collegium Pharmaceutical (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SCHEDULE 13G
09/17/2024
3:32 PM
Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
9:39 AM
Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
9:06 AM
Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
4:52 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
10:53 AM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:47 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:03 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
1:41 PM
Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:34 PM
Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
5:02 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:50 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2024
3:36 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
4:22 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
12:59 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
12:11 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
10:19 AM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144/A
05/29/2024
9:05 AM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
3:22 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
11:12 AM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
9:05 AM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
3:05 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
12:01 PM
Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COLL) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners